Global Anticancer Drug Market Growth (Status and Outlook) 2022-2028
- LP 4923813
- 88 Pages
- March 2022
- Pharmaceuticals
The United States Anticancer Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anticancer Drug market, reaching US$ million by the year 2028. As for the Europe Anticancer Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anticancer Drug players cover Roche, Celgene, Pfizer, and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticancer Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Targeted Drugs
Cytotoxic Drugs
Hormonal Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Immunotherapy
Targeted Therapy
Chemotherapy
Hormonal Therapy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Celgene
Pfizer
Bristol-Myers Squibb
Novartis
AstraZeneca
Teva Pharmaceuticals
Bayer
GlaxoSmithKline
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anticancer Drug Market Size 2017-2028
2.1.2 Anticancer Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anticancer Drug Segment by Type
2.2.1 Targeted Drugs
2.2.2 Cytotoxic Drugs
2.2.3 Hormonal Drugs
2.2.4 Others
2.3 Anticancer Drug Market Size by Type
2.3.1 Anticancer Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anticancer Drug Market Size Market Share by Type (2017-2022)
2.4 Anticancer Drug Segment by Application
2.4.1 Immunotherapy
2.4.2 Targeted Therapy
2.4.3 Chemotherapy
2.4.4 Hormonal Therapy
2.4.5 Others
2.5 Anticancer Drug Market Size by Application
2.5.1 Anticancer Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anticancer Drug Market Size Market Share by Application (2017-2022)
3 Anticancer Drug Market Size by Player
3.1 Anticancer Drug Market Size Market Share by Players
3.1.1 Global Anticancer Drug Revenue by Players (2020-2022)
3.1.2 Global Anticancer Drug Revenue Market Share by Players (2020-2022)
3.2 Global Anticancer Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anticancer Drug by Regions
4.1 Anticancer Drug Market Size by Regions (2017-2022)
4.2 Americas Anticancer Drug Market Size Growth (2017-2022)
4.3 APAC Anticancer Drug Market Size Growth (2017-2022)
4.4 Europe Anticancer Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa Anticancer Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anticancer Drug Market Size by Country (2017-2022)
5.2 Americas Anticancer Drug Market Size by Type (2017-2022)
5.3 Americas Anticancer Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anticancer Drug Market Size by Region (2017-2022)
6.2 APAC Anticancer Drug Market Size by Type (2017-2022)
6.3 APAC Anticancer Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anticancer Drug by Country (2017-2022)
7.2 Europe Anticancer Drug Market Size by Type (2017-2022)
7.3 Europe Anticancer Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anticancer Drug by Region (2017-2022)
8.2 Middle East & Africa Anticancer Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa Anticancer Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anticancer Drug Market Forecast
10.1 Global Anticancer Drug Forecast by Regions (2023-2028)
10.1.1 Global Anticancer Drug Forecast by Regions (2023-2028)
10.1.2 Americas Anticancer Drug Forecast
10.1.3 APAC Anticancer Drug Forecast
10.1.4 Europe Anticancer Drug Forecast
10.1.5 Middle East & Africa Anticancer Drug Forecast
10.2 Americas Anticancer Drug Forecast by Country (2023-2028)
10.2.1 United States Anticancer Drug Market Forecast
10.2.2 Canada Anticancer Drug Market Forecast
10.2.3 Mexico Anticancer Drug Market Forecast
10.2.4 Brazil Anticancer Drug Market Forecast
10.3 APAC Anticancer Drug Forecast by Region (2023-2028)
10.3.1 China Anticancer Drug Market Forecast
10.3.2 Japan Anticancer Drug Market Forecast
10.3.3 Korea Anticancer Drug Market Forecast
10.3.4 Southeast Asia Anticancer Drug Market Forecast
10.3.5 India Anticancer Drug Market Forecast
10.3.6 Australia Anticancer Drug Market Forecast
10.4 Europe Anticancer Drug Forecast by Country (2023-2028)
10.4.1 Germany Anticancer Drug Market Forecast
10.4.2 France Anticancer Drug Market Forecast
10.4.3 UK Anticancer Drug Market Forecast
10.4.4 Italy Anticancer Drug Market Forecast
10.4.5 Russia Anticancer Drug Market Forecast
10.5 Middle East & Africa Anticancer Drug Forecast by Region (2023-2028)
10.5.1 Egypt Anticancer Drug Market Forecast
10.5.2 South Africa Anticancer Drug Market Forecast
10.5.3 Israel Anticancer Drug Market Forecast
10.5.4 Turkey Anticancer Drug Market Forecast
10.5.5 GCC Countries Anticancer Drug Market Forecast
10.6 Global Anticancer Drug Forecast by Type (2023-2028)
10.7 Global Anticancer Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Anticancer Drug Product Offered
11.1.3 Roche Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Anticancer Drug Product Offered
11.2.3 Celgene Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Anticancer Drug Product Offered
11.3.3 Pfizer Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Anticancer Drug Product Offered
11.4.3 Bristol-Myers Squibb Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Anticancer Drug Product Offered
11.5.3 Novartis Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca Anticancer Drug Product Offered
11.6.3 AstraZeneca Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Information
11.7.2 Teva Pharmaceuticals Anticancer Drug Product Offered
11.7.3 Teva Pharmaceuticals Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Teva Pharmaceuticals Main Business Overview
11.7.5 Teva Pharmaceuticals Latest Developments
11.8 Bayer
11.8.1 Bayer Company Information
11.8.2 Bayer Anticancer Drug Product Offered
11.8.3 Bayer Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bayer Main Business Overview
11.8.5 Bayer Latest Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Information
11.9.2 GlaxoSmithKline Anticancer Drug Product Offered
11.9.3 GlaxoSmithKline Anticancer Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 GlaxoSmithKline Main Business Overview
11.9.5 GlaxoSmithKline Latest Developments
12 Research Findings and Conclusion
Table 1. Anticancer Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Targeted Drugs
Table 3. Major Players of Cytotoxic Drugs
Table 4. Major Players of Hormonal Drugs
Table 5. Major Players of Others
Table 6. Anticancer Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Anticancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Anticancer Drug Market Size Market Share by Type (2017-2022)
Table 9. Anticancer Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Anticancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Anticancer Drug Market Size Market Share by Application (2017-2022)
Table 12. Global Anticancer Drug Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Anticancer Drug Revenue Market Share by Player (2020-2022)
Table 14. Anticancer Drug Key Players Head office and Products Offered
Table 15. Anticancer Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anticancer Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Anticancer Drug Market Size Market Share by Regions (2017-2022)
Table 20. Americas Anticancer Drug Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Anticancer Drug Market Size Market Share by Country (2017-2022)
Table 22. Americas Anticancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Anticancer Drug Market Size Market Share by Type (2017-2022)
Table 24. Americas Anticancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Anticancer Drug Market Size Market Share by Application (2017-2022)
Table 26. APAC Anticancer Drug Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Anticancer Drug Market Size Market Share by Region (2017-2022)
Table 28. APAC Anticancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Anticancer Drug Market Size Market Share by Type (2017-2022)
Table 30. APAC Anticancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Anticancer Drug Market Size Market Share by Application (2017-2022)
Table 32. Europe Anticancer Drug Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Anticancer Drug Market Size Market Share by Country (2017-2022)
Table 34. Europe Anticancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Anticancer Drug Market Size Market Share by Type (2017-2022)
Table 36. Europe Anticancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Anticancer Drug Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Anticancer Drug Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anticancer Drug Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Anticancer Drug Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anticancer Drug Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Anticancer Drug Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anticancer Drug Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Anticancer Drug
Table 45. Key Market Challenges & Risks of Anticancer Drug
Table 46. Key Industry Trends of Anticancer Drug
Table 47. Global Anticancer Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Anticancer Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Anticancer Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Anticancer Drug Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Anticancer Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Anticancer Drug Market Size Market Share Forecast by Application (2023-2028)
Table 53. Roche Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 54. Roche Anticancer Drug Product Offered
Table 55. Roche Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Roche Main Business
Table 57. Roche Latest Developments
Table 58. Celgene Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 59. Celgene Anticancer Drug Product Offered
Table 60. Celgene Main Business
Table 61. Celgene Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Celgene Latest Developments
Table 63. Pfizer Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 64. Pfizer Anticancer Drug Product Offered
Table 65. Pfizer Main Business
Table 66. Pfizer Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Pfizer Latest Developments
Table 68. Bristol-Myers Squibb Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 69. Bristol-Myers Squibb Anticancer Drug Product Offered
Table 70. Bristol-Myers Squibb Main Business
Table 71. Bristol-Myers Squibb Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Bristol-Myers Squibb Latest Developments
Table 73. Novartis Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 74. Novartis Anticancer Drug Product Offered
Table 75. Novartis Main Business
Table 76. Novartis Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Novartis Latest Developments
Table 78. AstraZeneca Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 79. AstraZeneca Anticancer Drug Product Offered
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. AstraZeneca Latest Developments
Table 83. Teva Pharmaceuticals Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 84. Teva Pharmaceuticals Anticancer Drug Product Offered
Table 85. Teva Pharmaceuticals Main Business
Table 86. Teva Pharmaceuticals Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Bayer Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 89. Bayer Anticancer Drug Product Offered
Table 90. Bayer Main Business
Table 91. Bayer Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Bayer Latest Developments
Table 93. GlaxoSmithKline Details, Company Type, Anticancer Drug Area Served and Its Competitors
Table 94. GlaxoSmithKline Anticancer Drug Product Offered
Table 95. GlaxoSmithKline Main Business
Table 96. GlaxoSmithKline Anticancer Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. GlaxoSmithKline Latest Developments
List of Figures
Figure 1. Anticancer Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anticancer Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anticancer Drug Market Size Market Share by Type in 2021
Figure 7. Anticancer Drug in Immunotherapy
Figure 8. Global Anticancer Drug Market: Immunotherapy (2017-2022) & ($ Millions)
Figure 9. Anticancer Drug in Targeted Therapy
Figure 10. Global Anticancer Drug Market: Targeted Therapy (2017-2022) & ($ Millions)
Figure 11. Anticancer Drug in Chemotherapy
Figure 12. Global Anticancer Drug Market: Chemotherapy (2017-2022) & ($ Millions)
Figure 13. Anticancer Drug in Hormonal Therapy
Figure 14. Global Anticancer Drug Market: Hormonal Therapy (2017-2022) & ($ Millions)
Figure 15. Anticancer Drug in Others
Figure 16. Global Anticancer Drug Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Anticancer Drug Market Size Market Share by Application in 2021
Figure 18. Global Anticancer Drug Revenue Market Share by Player in 2021
Figure 19. Global Anticancer Drug Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Anticancer Drug Market Size 2017-2022 ($ Millions)
Figure 21. APAC Anticancer Drug Market Size 2017-2022 ($ Millions)
Figure 22. Europe Anticancer Drug Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Anticancer Drug Market Size 2017-2022 ($ Millions)
Figure 24. Americas Anticancer Drug Value Market Share by Country in 2021
Figure 25. Americas Anticancer Drug Consumption Market Share by Type in 2021
Figure 26. Americas Anticancer Drug Market Size Market Share by Application in 2021
Figure 27. United States Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Anticancer Drug Market Size Market Share by Region in 2021
Figure 32. APAC Anticancer Drug Market Size Market Share by Application in 2021
Figure 33. China Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Anticancer Drug Market Size Market Share by Country in 2021
Figure 40. Europe Anticancer Drug Market Size Market Share by Type in 2021
Figure 41. Europe Anticancer Drug Market Size Market Share by Application in 2021
Figure 42. Germany Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Anticancer Drug Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Anticancer Drug Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Anticancer Drug Market Size Market Share by Application in 2021
Figure 50. Egypt Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Anticancer Drug Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 56. APAC Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 57. Europe Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 59. United States Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 60. Canada Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 63. China Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 64. Japan Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 65. Korea Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 67. India Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 68. Australia Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 69. Germany Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 70. France Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 71. UK Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 72. Italy Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 73. Russia Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 74. Spain Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 77. Israel Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Anticancer Drug Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Anticancer Drug Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
